VistaGen Therapeutics Correlations

VTGN Stock

USD 2.69 0.09 3.46%

The current 90-days correlation between VistaGen Therapeutics and Entera Bio is 0.17 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VistaGen Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VistaGen Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

VistaGen Therapeutics Correlation With Market

Average diversification

The correlation between VistaGen Therapeutics and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding VistaGen Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VistaGen Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in VistaGen Stock, please use our How to Invest in VistaGen Therapeutics guide.

Moving together with VistaGen Stock

0.65	FDMT	4D Molecular Therapeutics	Pair Corr
0.7	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.67	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.8	MREO	Mereo BioPharma Group	Pair Corr
0.74	NKTX	Nkarta Inc Buyout Trend	Pair Corr
0.68	PEPG	PepGen	Pair Corr
0.7	PIRS	Pieris Pharmaceuticals	Pair Corr
0.76	ACRV	Acrivon Therapeutics,	Pair Corr
0.83	ADAP	Adaptimmune Therapeutics	Pair Corr
0.77	AFMD	Affimed NV	Pair Corr
0.62	APTO	Aptose Biosciences	Pair Corr
0.63	STOK	Stoke Therapeutics	Pair Corr
0.77	BDTX	Black Diamond Therap	Pair Corr

Moving against VistaGen Stock

0.74	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.58	NAMS	NewAmsterdam Pharma	Pair Corr
0.56	MNOV	MediciNova	Pair Corr
0.59	CRVS	Corvus Pharmaceuticals	Pair Corr
0.58	AVTE	Aerovate Therapeutics	Pair Corr
0.58	VREX	Varex Imaging Corp	Pair Corr
0.5	AGIO	Agios Pharm	Pair Corr
0.45	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.34	ANTX	AN2 Therapeutics	Pair Corr

Related Correlations Analysis

	SYBX	EFTR	GRTX	ICVX	ACIU	TCON	HSTO	ENTX	TPST	BTTX
SYBX		0.25	0.14	-0.22	0.51	0.21	0.15	0.45	0.61	-0.11	SYBX
EFTR	0.25		-0.15	-0.51	-0.09	0.76	0.16	-0.12	0.38	0.51	EFTR
GRTX	0.14	-0.15		0.18	0.34	-0.31	0.31	0.46	0.4	-0.36	GRTX
ICVX	-0.22	-0.51	0.18		0.04	-0.8	0.0	-0.22	-0.48	-0.63	ICVX
ACIU	0.51	-0.09	0.34	0.04		-0.17	-0.23	0.32	0.4	-0.5	ACIU
TCON	0.21	0.76	-0.31	-0.8	-0.17		0.08	-0.02	0.41	0.66	TCON
HSTO	0.15	0.16	0.31	0.0	-0.23	0.08		0.48	0.34	0.21	HSTO
ENTX	0.45	-0.12	0.46	-0.22	0.32	-0.02	0.48		0.57	-0.17	ENTX
TPST	0.61	0.38	0.4	-0.48	0.4	0.41	0.34	0.57		0.01	TPST
BTTX	-0.11	0.51	-0.36	-0.63	-0.5	0.66	0.21	-0.17	0.01		BTTX
	SYBX	EFTR	GRTX	ICVX	ACIU	TCON	HSTO	ENTX	TPST	BTTX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TCON	+ 0.76	EFTR
BTTX	+ 0.66	TCON
TPST	+ 0.61	SYBX
TPST	+ 0.57	ENTX
ACIU	+ 0.51	SYBX
BTTX	+ 0.51	EFTR

High negative correlations

TCON	- 0.8	ICVX
BTTX	- 0.63	ICVX
ICVX	- 0.51	EFTR
BTTX	- 0.5	ACIU
TPST	- 0.48	ICVX
BTTX	- 0.36	GRTX

Risk-Adjusted Indicators

There is a big difference between VistaGen Stock performing well and VistaGen Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze VistaGen Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SYBX	2.06	(0.05)	0.00	1.90	0.00	0.00	4.32	(2.80)	22.21
EFTR	7.57	(4.57)	0.00	(470.75)	0.00	0.00	8.70	(27.78)	88.91
GRTX	2.93	(0.15)	0.00	(0.03)	0.00	0.00	7.31	(5.84)	18.16
ICVX	4.87	0.93	0.17	1.58	4.56	(5.67)	10.22	(6.79)	38.57
ACIU	2.48	0.10	0.02	0.25	2.99	(2.93)	5.81	(4.63)	23.56
TCON	6.84	(1.55)	0.00	0.72	0.00	0.00	19.59	(17.77)	52.05
HSTO	4.52	(1.29)	0.00	1.17	0.00	0.00	4.76	(4.55)	131.40
ENTX	2.92	0.08	(0.02)	(0.31)	3.10	(3.93)	5.59	(5.47)	29.16
TPST	3.90	(0.60)	0.00	(0.58)	0.00	0.00	6.38	(8.53)	29.55
BTTX	4.55	(0.86)	0.00	(1.20)	0.00	0.00	12.64	(9.62)	36.53

VistaGen Therapeutics Corporate Management

CPA CPA	Chief Officer	Profile
Cynthia CPA	Chief Officer	Profile
Mark Ginski	Manufacturing Chemistry	Profile
Erik MD	Senior Pharmacovigilance	Profile
JD Esq	Chief Officer	Profile
Joshua MBA	Sr Operations	Profile
Jaakko MD	Senior Pharmacovigilance	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC